NCT04662502View on ClinicalTrials.gov

Efficacy of Bifidobacterium Longum 35624 on the Quality of Life of IBS Patients With Different Symptom Severity

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

November 22, 2018

Primary Completion Date

January 29, 2020

Study Completion Date

June 26, 2020

Conditions
Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

Bifidobacterium longum 35624

Bifidobacterium longum 35624, 1 x 10\^9 CFU/capsule, 1 capsule/day over 1 month

Trial Locations (1)

93009

Hôpital Avicenne, Bobigny

Sponsors

Lead Sponsor

Biocodex
All Listed Sponsors
lead

Biocodex

INDUSTRY